Connor Wathen

Dr. Connor Wathen


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2013 in Cancer Research
Verified
Journal Article
Closed access
CDCalli A. Davison
Calli A. Davison
SDSienna M. Durbin
Sienna M. Durbin
MTMatthew R. Thau
Matthew R. Thau
VZVictoria R. Zellmer
Victoria R. Zellmer
SCSarah E. Chapman
Sarah E. Chapman
ZSZachary T. Schafer
Zachary T. Schafer
Metastasis by cancer cells relies upon the acquisition of the ability to evade anoikis, a cell death process elicited by detachment from extracellular matrix (ECM). The molecular mechanisms that ECM-detached cancer cells use to survive are not understood. Striking increases in reactive oxygen species (ROS) occur in ECM-detached mammary epithelial cells, threatening cell viability by inhibiting ATP production, suggesting that ROS must be neutralized if cells are to survive ECM-detachment. Here, we report the discovery of a prominent role for antioxidant enzymes, including catalase and superoxide dismutase, in facilitating the survival of breast cancer cells after ECM-detachment. Enhanced expression of antioxidant enzymes in nonmalignant mammary epithelial cells detached from ECM resulted in ATP elevation and survival in the luminal space of mammary acini. Conversely, silencing antioxidant enzyme expression in multiple breast cancer cell lines caused ATP reduction and compromised anchorage-independent growth. Notably, antioxidant enzyme-deficient cancer cells were compromised in their ability to form tumors in mice. In aggregate, our results reveal a vital role for antioxidant enzyme activity in maintaining metabolic activity and anchorage-independent growth in breast cancer cells. Furthermore, these findings imply that eliminating antioxidant enzyme activity may be an effective strategy to enhance susceptibility to cell death in cancer cells that may otherwise survive ECM-detachment. Cancer Res; 73(12); 3704–15. ©2013 AACR.

27 May 2013 in Sensors
Verified
Journal Article
Open access
PDF file
CWConnor Wathen
Connor Wathen
NFNathan Foje
Nathan Foje
TATony Van Avermaete
Tony Van Avermaete
BMBernadette Miramontes
Bernadette Miramontes
SCSarah E. Chapaman
Sarah E. Chapaman
WLW. Matthew Leevy
W. Matthew Leevy
X-ray Computed Tomography (CT) is one of the most commonly utilized anatomical imaging modalities for both research and clinical purposes. CT combines high-resolution, three-dimensional data with relatively fast acquisition to provide a solid platform for non-invasive human or specimen imaging. The primary limitation of CT is its inability to distinguish many soft tissues based on native contrast. While bone has high contrast within a CT image due to its material density from calcium phosphate, soft tissue is less dense and many are homogenous in density. This presents a challenge in distinguishing one type of soft tissue from another. A couple exceptions include the lungs as well as fat, both of which have unique densities owing to the presence of air or bulk hydrocarbons, respectively. In order to facilitate X-ray CT imaging of other structures, a range of contrast agents have been developed to selectively identify and visualize the anatomical properties of individual tissues. Most agents incorporate atoms like iodine, gold, or barium because of their ability to absorb X-rays, and thus impart contrast to a given organ system. Here we review the strategies available to visualize lung, fat, brain, kidney, liver, spleen, vasculature, gastrointestinal tract, and liver tissues of living mice using either innate contrast, or commercial injectable or ingestible agents with selective perfusion. Further, we demonstrate how each of these approaches will facilitate the non-invasive, longitudinal, in vivo imaging of pre-clinical disease models at each anatomical site.

1 December 2016 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
CWConnor Wathen
Connor Wathen
VKVarun R. Kshettry
Varun R. Kshettry
AKAjit Krishnaney
Ajit Krishnaney
SGSteven M. Gordon
Steven M. Gordon
TFThomas Fraser
Thomas Fraser
AMAndre G. Machado
Andre G. Machado
BACKGROUND:. Surgical site infection (SSI) contributes significantly to postoperative morbidity and mortality and greatly increases the cost of care.OBJ

14 October 2023 in World Neurosurgery
Verified
Journal Article
Closed access
SMSneha Sai Mannam
Sneha Sai Mannam
RSRobert Subtirelu
Robert Subtirelu
DCDaksh Chauhan
Daksh Chauhan
HAHasan S. Ahmad
Hasan S. Ahmad
Irina-Mihaela MatacheIrina-Mihaela Matache
Irina-Mihaela Matache
JYJang Won Yoon
Jang Won Yoon

27 September 2017 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
HCHugh H. Chan
Hugh H. Chan
JCJessica Cooperrider
Jessica Cooperrider
ZCZhihong Chen
Zhihong Chen
JGJohn T. Gale
John T. Gale
KBKenneth B. Baker
Kenneth B. Baker
AMAndre G. Machado
Andre G. Machado
BACKGROUND: Chronic deep brain stimulation of the rodent lateral cerebellar nucleus (LCN) has been demonstrated to enhance motor recovery following cortical ischemia. This effect is concurrent with synaptogenesis and expression of long-term potentiation markers in the perilesional cerebral cortex. OBJECTIVE: To further investigate the cellular changes associated with chronic LCN stimulation in the ischemic rodent by examining neurogenesis along the cerebellothalamocortical pathway. METHODS: Rats were trained on the pasta matrix task, followed by induction of cortical ischemia and electrode implantation in the contralesional LCN. Electrical stimulation was initiated 6 wk after stroke induction and continued for 4 wk prior to sacrifice. Neurogenesis was examined using immunohistochemistry. RESULTS: Treated animals showed enhanced performance on the pasta matrix task relative to sham controls. Increased cell proliferation colabeled with 5’-Bromo-2’-deoxyuridine and neurogenic markers (doublecortin) was observed in the perilesional cortex as well as bilateral mediodorsal and ventrolateral thalamic subnuclei in treated vs untreated animals. The neurogenic effect at the level of motor cortex was selective, with stimulation-treated animals showing greater glutamatergic neurogenesis but significantly less GABAergic neurogenesis. CONCLUSION: These findings suggest that LCN deep brain stimulation modulates postinjury neurogenesis, providing a possible mechanistic foundation for the associated enhancement in poststroke motor recovery.